Related Experiment Video

Updated: Aug 29, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Neisseria meningitidis serogroup A vaccines: an overview

Stefania Vergnano1, Paul Heath

  • 1International Perinatal Unit, Institute of Child Health, 30 Guildford Street, London WC1N IE4, UK. svergnano@hotmail.com

Expert Review of Vaccines
|January 9, 2004
PubMed

Insights

Meningococcal epidemics caused by Neisseria meningitidis serogroup A remain a significant challenge in Africa. Despite available vaccines, past vaccination policies have been disappointing, highlighting the need for improved strategies.

Area of Science:

  • Epidemiology
  • Vaccinology
  • Public Health

Background:

  • Neisseria meningitidis serogroup A causes recurrent epidemics, particularly in Africa's resource-poor settings.
  • Past epidemics in the 1990s resulted in hundreds of thousands of meningitis cases and thousands of deaths.
  • Despite an effective polysaccharide vaccine since the 1970s, containment efforts have largely failed.

Purpose of the Study:

  • To describe the epidemiology of Neisseria meningitidis serogroup A.
  • To review existing polysaccharide vaccines, their benefits, and drawbacks.
  • To analyze current vaccination policies and economic factors contributing to disappointing vaccine use.

Main Methods:

  • Literature review of Neisseria meningitidis serogroup A epidemiology.
  • Analysis of historical epidemic data and vaccination campaign outcomes.
  • Discussion of polysaccharide vaccine efficacy and limitations.

Main Results:

  • Meningococcal epidemics persist as a major public health issue in Africa.
  • Polysaccharide vaccines, while available, have not effectively controlled epidemics due to surveillance and policy challenges.
  • The economic implications of current vaccination strategies are significant.

Conclusions:

  • Past vaccination policies for Neisseria meningitidis serogroup A have been disappointing.
  • There is a critical need to re-evaluate strategies for meningococcal disease control in Africa.
  • Recent advancements in conjugate vaccines offer promising new avenues for prevention.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...